pyrrolidonecarboxylic acid and Libman-Sacks Disease

pyrrolidonecarboxylic acid has been researched along with Libman-Sacks Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fu, C; Li, H; Li, K; Li, X; Li, Y; Liang, H; Qiu, Y; Wang, H; Yin, X; Zhang, Q; Zhang, X1

Other Studies

1 other study(ies) available for pyrrolidonecarboxylic acid and Libman-Sacks Disease

ArticleYear
Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2021, 02-01, Volume: 60, Issue:2

    Topics: Adult; Biomarkers; Case-Control Studies; Female; Humans; Lupus Erythematosus, Systemic; Metabolomics; Pyrrolidonecarboxylic Acid; ROC Curve

2021